These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 31066459

  • 1. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
    Lee SY, Jung W, Lee J, Kim A, Kim HK, Kim BH.
    Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
    [Abstract] [Full Text] [Related]

  • 2. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
    Yu L, Huang X, Zhang W, Zhao H, Wu G, Lv F, Shi L, Teng Y.
    Oncotarget; 2016 May 03; 7(18):26844-55. PubMed ID: 27057626
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
    Yi HC, Liu YL, You P, Pan JS, Zhou JY, Liu ZJ, Zhang ZY.
    Mol Med Rep; 2015 Feb 03; 11(2):1318-23. PubMed ID: 25351213
    [Abstract] [Full Text] [Related]

  • 4. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X, Zou L, Yao Q, Zhang Y, Gan L, Tang L.
    Oncol Rep; 2017 Aug 03; 38(2):1035-1042. PubMed ID: 28627610
    [Abstract] [Full Text] [Related]

  • 5. DEK oncogene is overexpressed during melanoma progression.
    Riveiro-Falkenbach E, Ruano Y, García-Martín RM, Lora D, Cifdaloz M, Acquadro F, Ballestín C, Ortiz-Romero PL, Soengas MS, Rodríguez-Peralto JL.
    Pigment Cell Melanoma Res; 2017 Mar 03; 30(2):194-202. PubMed ID: 27893188
    [Abstract] [Full Text] [Related]

  • 6. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X, Qi D, Qi J, Mao Z, Li X, Zhang J, Li J, Gao W.
    Oncol Rep; 2016 Jan 03; 35(1):155-62. PubMed ID: 26530274
    [Abstract] [Full Text] [Related]

  • 7. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
    Wang X, Lin L, Ren X, Lin Z, Li Z, Li C, Jin T.
    Int J Clin Exp Pathol; 2014 Jan 03; 7(8):5016-23. PubMed ID: 25197373
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
    Korita PV, Wakai T, Shirai Y, Matsuda Y, Sakata J, Cui X, Ajioka Y, Hatakeyama K.
    Hum Pathol; 2008 Dec 03; 39(12):1777-83. PubMed ID: 18701136
    [Abstract] [Full Text] [Related]

  • 9. Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma.
    Lu JW, Lin YM, Chang JG, Yeh KT, Chen RM, Tsai JJ, Su WW, Hu RM.
    Med Oncol; 2013 Mar 03; 30(1):379. PubMed ID: 23292829
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C, Wu M, Zong G, Wan C, Liu Q, Zhou H, Hua L, Chen Y, Chen X, Lu C.
    Dig Dis Sci; 2017 Jan 03; 62(1):133-142. PubMed ID: 27921263
    [Abstract] [Full Text] [Related]

  • 11. DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
    Yang MQ, Bai LL, Lei L, Zheng YW, Wang Z, Li ZH, Liu CC, Huang WJ, Xu HT.
    Oncol Rep; 2020 Apr 03; 43(4):1338-1348. PubMed ID: 32020224
    [Abstract] [Full Text] [Related]

  • 12. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
    Jin J, Jung HY, Wang Y, Xie J, Yeom YI, Jang JJ, Lee KB.
    Pathol Res Pract; 2014 Oct 03; 210(10):621-7. PubMed ID: 25160513
    [Abstract] [Full Text] [Related]

  • 13. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y, Liu J, Wang S, Luo X, Li Y, Lv Z, Zhu J, Lin J, Ding L, Ye Q.
    Oncotarget; 2016 Apr 26; 7(17):23740-56. PubMed ID: 26988756
    [Abstract] [Full Text] [Related]

  • 14. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J, Bi F, Yang Y, Zhang Y, Jin A, Li J, Lin Z.
    Oncol Rep; 2017 Feb 26; 37(2):857-864. PubMed ID: 27959420
    [Abstract] [Full Text] [Related]

  • 15. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
    Piao J, Shang Y, Liu S, Piao Y, Cui X, Li Y, Lin Z.
    Diagn Pathol; 2014 Mar 20; 9():67. PubMed ID: 24650035
    [Abstract] [Full Text] [Related]

  • 16. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
    Lin L, Piao J, Gao W, Piao Y, Jin G, Ma Y, Li J, Lin Z.
    BMC Cancer; 2013 Jul 31; 13():366. PubMed ID: 23902796
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DEK: A novel early screening and prognostic marker for breast cancer.
    Ying G, Wu Y.
    Mol Med Rep; 2015 Nov 31; 12(5):7491-5. PubMed ID: 26459608
    [Abstract] [Full Text] [Related]

  • 19. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
    Dong Y, Sui L, Sugimoto K, Tai Y, Tokuda M.
    Int J Cancer; 2001 Jul 20; 95(4):209-15. PubMed ID: 11400112
    [Abstract] [Full Text] [Related]

  • 20. Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice.
    Anna CH, Iida M, Sills RC, Devereux TR.
    Toxicol Appl Pharmacol; 2003 Jul 15; 190(2):135-45. PubMed ID: 12878043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.